Lisa Rivera

DOJ Brings Nationwide False Claims Act Lawsuit Against CVS For Alleged Violations Of Controlled Substances Act

Hospital Faces Serious Patient Lawsuits Stemming From Drug Diversion

Rite Aid And OptumRx Settlements Highlight Enforcement Focus On Pharmacy Corresponding Responsibility For Dispensing Controlled Substances

DEA Reaches $19 Million Administrative Settlement For Controlled Substances Act Violations

No Good (Corporate) Deed Goes Unpunished: Healthcare Providers May Be Sued By Employees For Reporting Controlled Substances Diversion

Final Rule To Allow For "One-Time Only" Transfer Of Electronic Controlled Substance Prescriptions Between Pharmacies

DEA Releases Updated Practitioner's Manual For Registrants Handling Controlled Substances

Perfection Not Required: Fifth Circuit Vacates HHS OCR $4.3 Million Penalty For Potential Data Breach Case

FDA Increases Scrutiny Of CBD Companies For Marketing And Labeling Practices

The Government Is Here To Help—For Now: What Your Company Should Be Doing Today To Protect Against Inevitable Government Scrutiny Of COVID-19 Relief Funding

How Health Care Companies Can Protect Against Government Scrutiny Of COVID-19 Relief Funding